Skip to content
Putting patients first: Why PBM reform must ensure that middlemen pass along 100% of rebates
This is the first in a series of Bio.News articles looking at the need for pharmacy benefit manager (PBM) reform through the lens of […]
BIO’s View
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
How utilization management blocks patient access
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit
As biotech breakthroughs enable remarkable advances in treatment and prevention of disease, we need similar levels of innovation in access, so patients benefit from
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit Read More »
BIO makes recommendation for new FDA Rare Disease Innovation Hub
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With the goal of engaging
BIO makes recommendation for new FDA Rare Disease Innovation Hub Read More »
CMS must address Part D plan abuse of IRA provisions designed to protect patient access
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for Medicare & Medicaid Services (CMS) take steps to protect patient access,
CMS must address Part D plan abuse of IRA provisions designed to protect patient access Read More »
Skyrocketing 340B program spending must prompt more hospital accountability
The 340B program grew by 24% in 2023, according to new figures from the government’s Health Resources and Services Administration. Sales at discounted prices
Skyrocketing 340B program spending must prompt more hospital accountability Read More »
A family, a firm, and a foundation fighting rare disease join BIO’s podcast
A family battling rare disease, a biopharma startup they’re assisting, and an organization seeking congressional support for new rare disease drugs share their journeys
A family, a firm, and a foundation fighting rare disease join BIO’s podcast Read More »
Development of non-opioid pain medicines threated by IRA’s ‘pill penalty’
The search for safer, effective replacements for opioids is a critical public health priority, but that effort is being undermined by the Inflation Reduction
Development of non-opioid pain medicines threated by IRA’s ‘pill penalty’ Read More »
As Medicare open enrollment nears, seniors will face difficult choices despite CMS’ rosy assessment
Prescription drug coverage in Medicare will see sweeping changes – for both health plans and for the millions of American seniors they serve –
Biotech bolsters food security amid climate challenges: I am BIO Podcast
As climate change threatens crops and shifts growing areas, maintaining food security requires the kinds of improvements to plant and animal farming that biotech
Biotech bolsters food security amid climate challenges: I am BIO Podcast Read More »